129 related articles for article (PubMed ID: 32554247)
21. Crizotinib prodrug micelles co-delivered doxorubicin for synergistic immunogenic cell death induction on breast cancer chemo-immunotherapy.
Liang Q; Lan Y; Li Y; Cao Y; Li J; Liu Y
Eur J Pharm Biopharm; 2022 Aug; 177():260-272. PubMed ID: 35863668
[TBL] [Abstract][Full Text] [Related]
22. EGFR-targeted prodrug activation using bioorthogonal alkene-azide click-and-release chemistry.
Fairhall JM; Camilli JC; Gibson BH; Hook S; Gamble AB
Bioorg Med Chem; 2021 Sep; 46():116361. PubMed ID: 34411983
[TBL] [Abstract][Full Text] [Related]
23. Tumor Ablation and Therapeutic Immunity Induction by an Injectable Peptide Hydrogel.
Jin H; Wan C; Zou Z; Zhao G; Zhang L; Geng Y; Chen T; Huang A; Jiang F; Feng JP; Lovell JF; Chen J; Wu G; Yang K
ACS Nano; 2018 Apr; 12(4):3295-3310. PubMed ID: 29558107
[TBL] [Abstract][Full Text] [Related]
24. Combined effects of avasimibe immunotherapy, doxorubicin chemotherapy, and metal-organic frameworks nanoparticles on breast cancer.
Lei J; Wang H; Zhu D; Wan Y; Yin L
J Cell Physiol; 2020 May; 235(5):4814-4823. PubMed ID: 31663620
[TBL] [Abstract][Full Text] [Related]
25. Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin.
Arabi L; Badiee A; Mosaffa F; Jaafari MR
J Control Release; 2015 Dec; 220(Pt A):275-286. PubMed ID: 26518722
[TBL] [Abstract][Full Text] [Related]
26. Surface-Layer Protein-Enhanced Immunotherapy Based on Cell Membrane-Coated Nanoparticles for the Effective Inhibition of Tumor Growth and Metastasis.
Wu M; Liu X; Bai H; Lai L; Chen Q; Huang G; Liu B; Tang G
ACS Appl Mater Interfaces; 2019 Mar; 11(10):9850-9859. PubMed ID: 30788951
[TBL] [Abstract][Full Text] [Related]
27. Targeted co-delivery of Trp-2 polypeptide and monophosphoryl lipid A by pH-sensitive poly (β-amino ester) nano-vaccines for melanoma.
Zou C; Jiang G; Gao X; Zhang W; Deng H; Zhang C; Ding J; Wei R; Wang X; Xi L; Tan S
Nanomedicine; 2019 Nov; 22():102092. PubMed ID: 31593795
[TBL] [Abstract][Full Text] [Related]
28. Combretastatin A4 Nanodrug-Induced MMP9 Amplification Boosts Tumor-Selective Release of Doxorubicin Prodrug.
Jiang J; Shen N; Ci T; Tang Z; Gu Z; Li G; Chen X
Adv Mater; 2019 Nov; 31(44):e1904278. PubMed ID: 31549774
[TBL] [Abstract][Full Text] [Related]
29. Fabricating an intelligent cell-like nano-prodrug via hierarchical self-assembly based on the DNA skeleton for suppressing lung metastasis of breast cancer.
Li Y; Yan T; Chang W; Cao C; Deng D
Biomater Sci; 2019 Aug; 7(9):3652-3661. PubMed ID: 31169833
[TBL] [Abstract][Full Text] [Related]
30. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
[TBL] [Abstract][Full Text] [Related]
31. Engineering Endogenous Tumor-Associated Macrophage-Targeted Biomimetic Nano-RBC to Reprogram Tumor Immunosuppressive Microenvironment for Enhanced Chemo-Immunotherapy.
Wang Y; Yu J; Luo Z; Shi Q; Liu G; Wu F; Wang Z; Huang Y; Zhou D
Adv Mater; 2021 Oct; 33(39):e2103497. PubMed ID: 34387375
[TBL] [Abstract][Full Text] [Related]
32. Prophylactic immunization with Bubble liposomes and ultrasound-treated dendritic cells provided a four-fold decrease in the frequency of melanoma lung metastasis.
Oda Y; Suzuki R; Otake S; Nishiie N; Hirata K; Koshima R; Nomura T; Utoguchi N; Kudo N; Tachibana K; Maruyama K
J Control Release; 2012 Jun; 160(2):362-6. PubMed ID: 22192573
[TBL] [Abstract][Full Text] [Related]
33. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
34. Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma.
Guo Y; Wang D; Song Q; Wu T; Zhuang X; Bao Y; Kong M; Qi Y; Tan S; Zhang Z
ACS Nano; 2015 Jul; 9(7):6918-33. PubMed ID: 26153897
[TBL] [Abstract][Full Text] [Related]
35. Isoginkgetin derivative IP2 enhances the adaptive immune response against tumor antigens.
Darrigrand R; Pierson A; Rouillon M; Renko D; Boulpicante M; Bouyssié D; Mouton-Barbosa E; Marcoux J; Garcia C; Ghosh M; Alami M; Apcher S
Commun Biol; 2021 Mar; 4(1):269. PubMed ID: 33649389
[TBL] [Abstract][Full Text] [Related]
36. Tumor microenvironment-activated therapeutic peptide-conjugated prodrug nanoparticles for enhanced tumor penetration and local T cell activation in the tumor microenvironment.
Zhu X; Li C; Lu Y; Liu Y; Wan D; Zhu D; Pan J; Ma G
Acta Biomater; 2021 Jan; 119():337-348. PubMed ID: 33166712
[TBL] [Abstract][Full Text] [Related]
37. Polymeric prodrug microspheres with tumor intracellular microenvironment bioreducible degradation, pH-triggered "off-on" fluorescence and drug release for precise imaging-guided diagnosis and chemotherapy.
Pei M; Li G; Ma K; Li J; Wang Y; Liu P
Colloids Surf B Biointerfaces; 2019 May; 177():313-320. PubMed ID: 30771583
[TBL] [Abstract][Full Text] [Related]
38. mTOR inhibition improves antitumor effects of vaccination with antigen-encoding RNA.
Diken M; Kreiter S; Vascotto F; Selmi A; Attig S; Diekmann J; Huber C; Türeci Ö; Sahin U
Cancer Immunol Res; 2013 Dec; 1(6):386-92. PubMed ID: 24778131
[TBL] [Abstract][Full Text] [Related]
39. Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells.
Foy SP; Mandl SJ; dela Cruz T; Cote JJ; Gordon EJ; Trent E; Delcayre A; Breitmeyer J; Franzusoff A; Rountree RB
Cancer Immunol Immunother; 2016 May; 65(5):537-49. PubMed ID: 26961085
[TBL] [Abstract][Full Text] [Related]
40. Synergistic action of doxorubicin and 7-Ethyl-10-hydroxycamptothecin polyphosphorylcholine polymer prodrug.
Wu Z; Li S; Cai Y; Chen F; Chen Y; Luo X
Colloids Surf B Biointerfaces; 2020 May; 189():110741. PubMed ID: 32032928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
